Could This News Spark a Turnaround for Ocugen?
Ocugen (NASDAQ: OCGN) shares were flying high earlier this year. The company signed a deal with India's Bharat Biotech for co-commercialization rights to its coronavirus vaccine candidate in the U.S. The Bharat product was close to market. And data were looking good. Since then, Ocugen learned it wouldn't win the right to sell the vaccine in the U.S. as soon as it had hoped. And the shares suffered.
In recent days, however, Ocugen stock has made a bit of a comeback. The stock even gained as much as 15% in one trading session on a particular bit of news. Now the question is whether this news could lead to a permanent turnaround for Ocugen's shares. Let's take a closer look.
Image source: Getty Images.
Source Fool.com
